BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17116124)

  • 21. Efficacy of a paracetamol-pseudoephedrine combination for treatment of nasal congestion and pain-related symptoms in upper respiratory tract infection.
    Eccles R; Jawad M; Jawad S; Ridge D; North M; Jones E; Burnett I
    Curr Med Res Opin; 2006 Dec; 22(12):2411-8. PubMed ID: 17257455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-administration of (+)-methamphetamine and (+)-pseudoephedrine, alone and combined, by rhesus monkeys.
    Freeman KB; Wang Z; Woolverton WL
    Pharmacol Biochem Behav; 2010 Apr; 95(2):198-202. PubMed ID: 20100506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review of methamphetamine precursor regulations.
    McKetin R; Sutherland R; Bright DA; Norberg MM
    Addiction; 2011 Nov; 106(11):1911-24. PubMed ID: 21895829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold.
    Eccles R; Jawad MS; Jawad SS; Angello JT; Druce HM
    Am J Rhinol; 2005; 19(1):25-31. PubMed ID: 15794071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ischemic colitis caused by decongestant?
    Schneider RP
    J Clin Gastroenterol; 1995 Dec; 21(4):335-6. PubMed ID: 8583118
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
    Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
    Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits.
    Suh SH; Chon KM; Min YG; Jeong CH; Hong SH
    Acta Otolaryngol; 1995 Sep; 115(5):664-71. PubMed ID: 8928640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myocardial infarction after over-the-counter use of pseudoephedrine.
    Manini AF; Kabrhel C; Thomsen TW
    Ann Emerg Med; 2005 Feb; 45(2):213-6. PubMed ID: 15671979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impacts of federal precursor chemical regulations on methamphetamine arrests.
    Cunningham JK; Liu LM
    Addiction; 2005 Apr; 100(4):479-88. PubMed ID: 15784062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysing pseudoephedrine/methamphetamine policy options in Australia using multi-criteria decision modelling.
    Manning M; Wong GT; Ransley J; Smith C
    Int J Drug Policy; 2016 Jun; 32():85-92. PubMed ID: 27179610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mexico's methamphetamine precursor chemical interventions: impacts on drug treatment admissions.
    Cunningham JK; Bojorquez I; Campollo O; Liu LM; Maxwell JC
    Addiction; 2010 Nov; 105(11):1973-83. PubMed ID: 20707864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of oral phenylephrine: systematic review and meta-analysis.
    Hatton RC; Winterstein AG; McKelvey RP; Shuster J; Hendeles L
    Ann Pharmacother; 2007 Mar; 41(3):381-90. PubMed ID: 17264159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nasal decongestion on nasalance measures.
    Pegoraro-Krook MI; Dutka-Souza JC; Williams WN; Teles Magalhães LC; Rossetto PC; Riski JE
    Cleft Palate Craniofac J; 2006 May; 43(3):289-94. PubMed ID: 16681401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up on the Combat Methamphetamine Epidemic Act of 2005: review of oral decongestants.
    Luckower T
    J Am Pharm Assoc (2003); 2007; 47(1):4-5, 8. PubMed ID: 17338467
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral antihistamine-decongestant-analgesic combinations for the common cold.
    De Sutter AI; van Driel ML; Kumar AA; Lesslar O; Skrt A
    Cochrane Database Syst Rev; 2012 Feb; (2):CD004976. PubMed ID: 22336807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment.
    Cunningham JK; Liu LM
    Soc Sci Med; 2008 Apr; 66(7):1463-73. PubMed ID: 18222587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WITHDRAWN: Nasal decongestants for the common cold.
    Taverner D; Latte GJ
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD001953. PubMed ID: 19370573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasal decongestants for the common cold.
    Taverner D; Latte J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001953. PubMed ID: 17253470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.
    Georgitis JW; Meltzer EO; Kaliner M; Weiler J; Berkowitz R
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of pseudoephedrine sales restrictions on emergency department urine drug screen results in Oklahoma.
    Brandenburg MA; Brown SJ; Arneson WL; Arneson DL
    J Okla State Med Assoc; 2007 Nov; 100(11):436-9. PubMed ID: 18183861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.